Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Change in Inventory (2020)

Updated

Grace Therapeutics (GRCE) posted Change in Inventory of $14,000 for fiscal Q3 2021 (quarter ended Dec 31, 2020).

Analysis

Grace Therapeutics (GRCE) Change in Inventory (2020) Analysis & Trends

For FY2016 (ended Feb 29, 2016), Grace Therapeutics' Change in Inventory came in at $67,525.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Inventory (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 571.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 143.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 31.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 145.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Grace Therapeutics 34.02 Mn -32.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 14,000.00
API Access

Grace Therapeutics Change in Inventory API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-inventory&ticker=GRCE&period=max&api_key=YOUR_API_KEY